Skip to main content

Frequency of Blood Phosphate Monitoring Following Ferric Carboxymaltose (FCM) Administration in Patients in the Sentinel Distributed Database: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Description

In this analysis, we assessed frequency of blood phosphate monitoring before and after ferric carboxymaltose (FCM) administration in the Sentinel Distributed Database (SDD).

The study period includes data from January 1, 2017 to March 31, 2025. We distributed this request to six Data Partners in the Sentinel Distributed Database on August 27, 2025.

Deliverables (1)
Sentinel Modular Program Report: Frequency of Blood Phosphate Monitoring Following Ferric Carboxymaltose (FCM) Administration in Patients in the Sentinel Distributed Database: A Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
January 1, 2017 - March 31, 2025
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: Injectafer (ferric carboxymaltose, FCM) & Serum Phosphate Testing